Court sides with United Therapeutics in suit from generic competitor, but doesn't dismiss case
February 05, 2020 at 15:01 PM EST
A federal has denied an injunction motion from Sandoz and RareGen, the companies selling a generic form of a drug that United Therapeutics had under patent until early 2019.
